CN114431312A - Black tea active powder and solid beverage thereof - Google Patents
Black tea active powder and solid beverage thereof Download PDFInfo
- Publication number
- CN114431312A CN114431312A CN202210081820.2A CN202210081820A CN114431312A CN 114431312 A CN114431312 A CN 114431312A CN 202210081820 A CN202210081820 A CN 202210081820A CN 114431312 A CN114431312 A CN 114431312A
- Authority
- CN
- China
- Prior art keywords
- active powder
- black tea
- tea active
- solid beverage
- eurotium cristatum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/08—Oxidation; Fermentation
- A23F3/10—Fermentation with addition of microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A black tea active powder and a solid beverage thereof relate to the technical field of food production, the preparation process of the black tea active powder comprises the steps of carrying out liquid fermentation and enrichment on eurotium cristatum to obtain mycelium of eurotium cristatum, simultaneously adding chlorogenic acid in the fermentation process, freeze-drying the mycelium into the black tea active powder by a freeze-drying process after the fermentation is finished, assisting the liquid fermentation of the eurotium cristatum, enabling the chlorogenic acid which is easy to deteriorate and cannot be absorbed to exist in the black tea active powder in a form of bacterial powder to be absorbed and utilized, and simultaneously playing a certain bacteriostatic role, so that the black tea active powder also has the beneficial effects of reducing internal heat and reducing fat, resisting bacteria, resisting tumors and the like, the solid beverage contains the black tea active powder, and the fixed beverage comprises the solid beverage of the blood sugar-reducing black tea active powder, the solid beverage of the blood fat-reducing black tea active powder and the solid beverage of the acid-reducing black tea active powder.
Description
Technical Field
The invention relates to the technical field of food production, in particular to dark green tea active powder and a solid beverage thereof.
Background
Fuzhuan tea is one kind of dark tea, and belongs to post-fermentation tea. The functional components in the Fuzhuan tea, such as lipopolysaccharide, tea polyphenol, tea polysaccharide, gamma-aminobutyric acid, tea pigment and the like, have the functions of reducing blood sugar and blood fat, resisting oxidation and improving the immunity of the organism.
Meanwhile, the Fuzhuan tea is rich in eurotium cristatum (commonly called as golden flower) beneficial to a human body, and the eurotium cristatum can convert protein and starch in the tea into monosaccharide and catalyze polyphenol compounds to be oxidized, so that substances beneficial to the human body are converted, the immunity of the body is improved, the blood fat is reduced, and intestinal flora is adjusted. The eurotium cristatum is mostly applied to the tea fermentation process, has less application and development in food, and has larger market prospect.
Chlorogenic acid is one of effective pharmacological components of honeysuckle capable of resisting bacteria and viruses, has wide biological activity, and has multiple effects of resisting bacteria, viruses and oxidation, protecting liver and gallbladder, resisting tumors, reducing blood fat, eliminating free radicals, exciting central nervous system and the like. However, chlorogenic acid as a polar organic acid is unstable in property and easy to deteriorate, so that it cannot be effectively absorbed and utilized by human bodies.
Therefore, the invention provides the black tea active powder rich in chlorogenic acid and the solid beverage thereof.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide black tea active powder, in order to enrich and culture Eurotium cristatum, the black tea active powder is obtained by a freeze-drying technology, and meanwhile, chlorogenic acid which is easy to deteriorate and cannot be absorbed is convenient to be absorbed and utilized by a human body in a bacterial powder form through hypha generated by liquid fermentation, and the specific scheme is as follows:
a black tea active powder is prepared by liquid state fermentation and enrichment of Eurotium cristatum to obtain mycelium of Eurotium cristatum, simultaneously adding chlorogenic acid during fermentation, and freeze-drying the mycelium to obtain the black tea active powder by freeze-drying process after fermentation.
Furthermore, in the black tea active powder, chlorogenic acid is in a bacterial powder form and is convenient to absorb and utilize by a human body.
Further, the preparation process comprises the following steps: obtaining strains → purifying and domesticating strains → enriching strains → obtaining mycelium → freeze-dried mycelium → crushing solid fermentation broth → obtaining black tea active powder.
Further, the strain obtaining step specifically comprises: taking off tea leaves containing more Eurotium cristatum from Fuzhuan tea, inoculating the tea leaves to a cooled and solidified PDA culture medium, and placing the PDA culture medium in an incubator for culturing for 3 days, wherein the culture temperature is set to be 36 ℃.
Further, the strain purification and domestication steps are specifically as follows: taking a good Eurotium cristatum from a culture medium for culturing Eurotium cristatum, inoculating to a cooled and solidified PDA culture medium containing tea polyphenols and chlorogenic acid, and culturing in an incubator at 36 deg.C for 3 days.
Further, the strain enrichment specifically comprises the following steps: taking a piece of eurotium cristatum with excellent growth vigor from a culture medium for culturing eurotium cristatum which is tolerant to the environment of tea polyphenol and chlorogenic acid, adding the eurotium cristatum into a PDW culture solution containing the tea polyphenol and the chlorogenic acid, placing the PDW culture solution in a constant-temperature culture shaking table for culturing for 3 days at the temperature of 36 +/-1 ℃ and the rotating speed of 180r/min, and scattering spores to obtain a bacterial solution enriched with eurotium cristatum mycelium pellets.
Further, the step of obtaining mycelium specifically comprises: adding 5L of distilled water into a reaction kettle, sequentially adding tea polyphenol accounting for 5 percent of the total weight of the water, chlorogenic acid accounting for 5 percent of the total weight of the water, eurotium cristatum liquid accounting for 5 percent of the total weight of the water and fungus-culturing brown sugar accounting for 5 percent of the total weight of the water, stirring for 1 hour, setting the stirring condition to be 30r/min, and then naturally fermenting, wherein the temperature condition is controlled to be 36 +/-1 ℃ and the fermentation time is 2 weeks.
Further, the steps of freeze-dried mycelium → crushed solid fermentation liquid → black tea active powder are as follows: and after the fermentation is finished, taking out the fermentation liquor containing a large amount of mycelia, performing membrane filtration to obtain pure fermentation liquor, performing freeze-drying by using a freeze dryer to obtain solid fermentation liquor, and crushing by using a crusher to obtain the required black tea active powder.
The solid beverage contains the dark green tea active powder, and the fixed beverage comprises the blood sugar-reducing dark green tea active powder solid beverage, the blood fat-reducing dark green tea active powder solid beverage and the acid-reducing dark green tea active powder solid beverage.
Further, the formula of the blood sugar-reducing dark green tea active powder solid beverage comprises: 20% of black tea active powder, 5% of dihydromyricetin, 2.5% of stevioside, 1.8% of mogroside, 33.3% of inulin, 10% of galacto-oligosaccharide, 12.3% of xylo-oligosaccharide, 5% of yeast beta-glucan and 10% of soybean phospholipid;
the formula of the lipid-lowering dark green tea active powder solid beverage comprises: 16.7% of black tea active powder, 2% of nuciferine, 3% of glycyrrhizic acid, 13.3% of galacto-oligosaccharide, 1.7% of mogroside, 6.7% of yeast beta-glucan, 6.7% of vitamin C, 8.3% of chitosan oligosaccharide, 1.7% of stevioside and 40% of inulin;
the formula of the acid-reducing dark green tea active powder solid beverage comprises: 18.3% of black tea active powder, 15% of potassium citrate, 10% of citric acid, 2% of pachyman, 30% of maltitol, 2.7% of stevioside, 2% of gamma-aminobutyric acid, 1% of vitamin C and 23.3% of soybean polysaccharide.
Compared with the prior art, the invention has the following beneficial effects:
(1) according to the black tea active powder provided by the invention, by virtue of liquid fermentation of eurotium cristatum, chlorogenic acid which is easy to deteriorate and cannot be absorbed exists in the black tea active powder in the form of bacterial powder, can be absorbed and utilized, and plays a certain antibacterial role, so that the black tea active powder also has the beneficial effects of reducing internal heat and reducing fat, resisting bacteria, resisting tumors and the like;
(2) through the preparation process of the black tea active powder, the strain obtained in the first step is purified and domesticated to enable eurotium cristatum to be resistant to the environment of tea polyphenol and chlorogenic acid, a large number of dominant strains are primarily enriched, the strain foundation is laid for the subsequent strain enrichment step, the strain enrichment step is used for obtaining the bacterial liquid further enriched with eurotium cristatum mycelium pellets, the step of obtaining mycelium is carried out, the long-time fermentation is carried out to enable the dominant strain of the eurotium cristatum tolerant to the chlorogenic acid and the tea polyphenol to grow in a large number under the condition of bacteria-cultivating brown sugar, the enrichment culture is used for obtaining the mycelium of the eurotium cristatum, the mycelium contains chlorogenic acid components, the compounding of the chlorogenic acid and the eurotium cristatum is basically finished, the final black tea active powder with excellent quality is obtained through the subsequent freeze-drying and crushing steps, and the black tea active powder has the functions of improving human immunity, Preventing tumor, reducing blood lipid, reducing weight, resisting oxidation, and inhibiting bacteria;
(3) the formula of the hypoglycemic dark green tea active powder solid beverage contains functional components such as dark green tea active powder, dihydromyricetin, inulin, yeast beta-glucan and the like, has the beneficial effects of reducing blood sugar, resisting bacteria, resisting oxidation and the like, and meanwhile, adopts natural sweetening agents such as stevioside, mogroside, galacto-oligosaccharide and the like for flavoring, improves the taste, has extremely low heat, and cannot cause burden to a human body;
the formula of the lipid-lowering dark tea active powder solid beverage contains effective components such as dark tea active powder, nuciferine, inulin, yeast beta-glucan and the like, and has the beneficial effects of lipid lowering, antibiosis, free radical resistance and the like. Meanwhile, the natural sweetening agents such as glycyrrhizic acid, mogroside, galacto-oligosaccharide and the like are adopted for flavoring, so that the taste is improved, the heat is extremely low, and the burden on a human body is avoided;
the acid-reducing dark tea active powder solid beverage formula contains dark tea active powder, potassium citrate, pachyman, gamma-aminobutyric acid and other functional components, has the beneficial effects of balancing uric acid, preventing urinary calculus, reducing gout probability and the like, and is flavored by citric acid, maltitol, stevioside and other natural sweeteners, so that the taste is improved, the calorie is extremely low, and no burden is caused on a human body.
Drawings
FIG. 1 is a schematic diagram showing the auxiliary effect obtained by the strains in the present invention;
FIG. 2 is a schematic diagram showing the auxiliary effect of strain purification and domestication in the present invention;
FIG. 3 is a schematic diagram showing the auxiliary effect of constant temperature shaking table cultivation in the present invention;
FIG. 4 is a schematic diagram showing the auxiliary effect of the bacterial liquid enriched in mycelial pellets of Eurotium cristatum in the present invention;
FIG. 5 is a schematic diagram showing the auxiliary effect of a reaction kettle containing 5% of bacterial liquid, 5% of bacteria-cultivating brown sugar, 5% of tea polyphenol and 5% of chlorogenic acid in the present invention;
fig. 6 is a schematic diagram showing the auxiliary effect of the pulverized dark tea active powder in the present invention.
Detailed Description
The present invention will be described in further detail with reference to examples and drawings, but the present invention is not limited to these examples.
A black tea active powder is prepared by liquid-state fermentation and enrichment of Eurotium cristatum to obtain mycelium of Eurotium cristatum, adding chlorogenic acid during fermentation, and freeze-drying the mycelium to obtain black tea active powder. Correspondingly, the preparation process comprises the following steps: obtaining strains → purifying and domesticating strains → enriching strains → obtaining mycelium → freeze-dried mycelium → crushing solid fermentation broth → obtaining black tea active powder.
In the black tea active powder, as chlorogenic acid is added in the process of liquid fermentation of eurotium cristatum, the chlorogenic acid exists in the black tea active powder in a fungus powder form finally, and the chlorogenic acid can be absorbed and utilized by a human body after the black tea active powder is eaten.
In order to further disclose the preparation process of the black tea active powder, the specific contents are as follows:
obtaining strains: taking off tea leaves containing more Eurotium cristatum from Fuzhuan tea, inoculating the tea leaves to a cooled and solidified PDA culture medium, and placing the PDA culture medium in an incubator for culturing for 3 days, wherein the culture temperature is set to be 36 ℃.
And (3) strain purification and domestication: taking a good Eurotium cristatum from a culture medium for culturing Eurotium cristatum, inoculating to a cooled and solidified PDA culture medium containing tea polyphenols and chlorogenic acid, and culturing in an incubator at 36 deg.C for 3 days. The purpose of the step is to make the Eurotium cristatum tolerant to the environment of tea polyphenol and chlorogenic acid, enrich a large number of dominant strains, lay a strain foundation for the subsequent strain enrichment step, provide excellent strains and reduce the possibility of failure of the whole process caused by the bad strains in the early stage.
Strain enrichment: taking a piece of eurotium cristatum with excellent growth vigor from a culture medium for culturing eurotium cristatum which is tolerant to the environment of tea polyphenol and chlorogenic acid, adding the eurotium cristatum into a PDW culture solution containing the tea polyphenol and the chlorogenic acid, placing the PDW culture solution in a constant-temperature culture shaking table for culturing for 3 days at the temperature of 36 +/-1 ℃ and the rotating speed of 180r/min, and scattering spores to obtain a bacterial solution enriched with eurotium cristatum mycelium pellets.
Obtaining mycelium: adding 5L of distilled water into a reaction kettle, sequentially adding tea polyphenol accounting for 5 percent of the total weight of the water, chlorogenic acid accounting for 5 percent of the total weight of the water, eurotium cristatum liquid accounting for 5 percent of the total weight of the water and fungus-culturing brown sugar accounting for 5 percent of the total weight of the water, and stirring for 1 hour under the stirring condition of 30 r/min. Then naturally fermenting, controlling the temperature condition at 36 +/-1 ℃ and the fermentation time at 2 weeks. The setting of the step enables the dominant strain of eurotium cristatum which is tolerant to chlorogenic acid and tea polyphenol to grow in a large amount under the condition of bacteria-raising brown sugar, the mycelium of eurotium cristatum is obtained through enrichment culture, the mycelium contains chlorogenic acid, and at the moment, the chlorogenic acid is compounded in the eurotium cristatum.
And after the fermentation is finished, taking out the fermentation liquor containing a large amount of mycelia, performing membrane filtration to obtain pure fermentation liquor, performing freeze-drying by using a freeze dryer to obtain solid fermentation liquor, and crushing by using a crusher to obtain the required black tea active powder.
The invention also provides a solid beverage containing the dark green tea active powder aiming at the dark green tea active powder, and the fixed beverage comprises the blood sugar-reducing dark green tea active powder solid beverage, the blood fat-reducing dark green tea active powder solid beverage and the acid-reducing dark green tea active powder solid beverage.
Example 1: black tea active powder solid beverage capable of reducing blood sugar
The formula of the black tea active powder solid beverage for reducing blood sugar is as follows: 20% of black tea active powder, 5% of dihydromyricetin, 2.5% of stevioside, 1.8% of mogroside, 33.3% of inulin, 10% of galacto-oligosaccharide, 12.3% of xylo-oligosaccharide, 5% of yeast beta-glucan and 10% of soybean phospholipid.
And (3) granulating: weighing the required dosage according to the formula, carrying out wet granulation, and using pure water as an adhesive. And (3) carrying out swing granulation on the material subjected to wet granulation by using a swing granulator, wherein the mesh number of a screen of the swing granulator is 50. The material after the swing granulation was dried at 70 ℃ (± 2 ℃) to a moisture content of 2% -4%. The dried granules were granulated by a granulator. The aperture of the screen mesh of the granulator is 3.3 mm. And (5) packaging the dry-mixed and uniform materials into small bags.
The efficacy of the hypoglycemic dark green tea active powder solid beverage of example 1 shows that: the formula contains functional components such as black tea active powder, dihydromyricetin, inulin, yeast beta-glucan and the like, has the beneficial effects of reducing blood sugar, resisting bacteria, resisting oxidation and the like, and adopts natural sweetening agents such as stevioside, mogroside, galacto-oligosaccharide and the like for flavoring, so that the heat is extremely low while the taste is improved, and no burden is caused on a human body.
Example 2: lipid-lowering dark green tea active powder solid beverage
The formula of the lipid-lowering dark green tea active powder solid beverage comprises: 16.7% of black tea active powder, 2% of nuciferine, 3% of glycyrrhizic acid, 13.3% of galacto-oligosaccharide, 1.7% of mogroside, 6.7% of yeast beta-glucan, 6.7% of vitamin C, 8.3% of chitosan oligosaccharide, 1.7% of stevioside and 40% of inulin.
And (3) granulating: weighing the required dosage according to the formula, carrying out wet granulation, and using pure water as an adhesive. And (3) carrying out swing granulation on the material subjected to wet granulation by using a swing granulator, wherein the mesh number of a screen of the swing granulator is 50. The material after the swing granulation was dried at 70 ℃ (± 2 ℃) to a moisture content of 2% -4%. The dried granules were granulated by a granulator. The aperture of the screen mesh of the granulator is 3.3 mm. And (5) packaging the dry-mixed and uniform materials into small bags.
Efficacy of the lipid-lowering dark tea active powder solid beverage of example 2 illustrates: the formula contains active black tea powder, nuciferine, inulin, yeast beta-glucan and other functional components, and has the beneficial effects of reducing blood fat, resisting bacteria, resisting free radicals and the like. Meanwhile, the natural sweetening agents such as glycyrrhizic acid, mogroside, galacto-oligosaccharide and the like are adopted for flavoring, so that the taste is improved, the heat is extremely low, and the burden on a human body is avoided.
Example 3: acid-reducing dark green tea active powder solid beverage
The formula of the acid-reducing dark green tea active powder solid beverage comprises: 18.3% of black tea active powder, 15% of potassium citrate, 10% of citric acid, 2% of pachyman, 30% of maltitol, 2.7% of stevioside, 2% of gamma-aminobutyric acid, 1% of vitamin C and 23.3% of soybean polysaccharide.
And (3) granulating: weighing the required dosage according to the formula, carrying out wet granulation, and using pure water as an adhesive. And (3) carrying out swing granulation on the material subjected to wet granulation by using a swing granulator, wherein the mesh number of a screen of the swing granulator is 50. The material after the swing granulation was dried at 70 ℃ (± 2 ℃) to a moisture content of 2% -4%. The dried granules were granulated by a granulator. The aperture of the screen mesh of the granulator is 3.3 mm. And (5) packaging the dry-mixed and uniform materials into small bags.
Efficacy of the acid-reducing dark tea active powder solid beverage of example 3 illustrates: the formula contains active black tea powder, potassium citrate, pachyman, gamma-aminobutyric acid and other functional components, has the beneficial effects of balancing uric acid, preventing urinary calculus, reducing gout probability and the like, and is flavored by using citric acid, maltitol, stevioside and other natural sweeteners, so that the taste is improved, the heat is extremely low, and no burden is caused on a human body.
The above description is only a preferred embodiment of the present invention, and the protection scope of the present invention is not limited to the above embodiments, and all technical solutions belonging to the idea of the present invention belong to the protection scope of the present invention. It should be noted that modifications and embellishments within the scope of the invention may occur to those skilled in the art without departing from the principle of the invention, and are considered to be within the scope of the invention.
Claims (10)
1. The preparation process of the black tea active powder is characterized in that the mycelium of eurotium cristatum is obtained by liquid fermentation and enrichment of eurotium cristatum, chlorogenic acid is added in the fermentation process, and after the fermentation is finished, the mycelium is freeze-dried into the black tea active powder by a freeze-drying process.
2. The black tea active powder according to claim 1, wherein chlorogenic acid in the black tea active powder is in a form of bacterial powder and is easily absorbed and utilized by a human body.
3. The black tea active powder according to claim 2, wherein the preparation process comprises the following steps: obtaining strains → purifying and domesticating strains → enriching strains → obtaining mycelium → freeze-dried mycelium → crushing solid fermentation broth → obtaining black tea active powder.
4. The black tea active powder according to claim 3, wherein the strain is obtained by the following specific steps: taking off tea leaves containing more Eurotium cristatum from Fuzhuan tea, inoculating the tea leaves to a cooled and solidified PDA culture medium, and placing the PDA culture medium in an incubator for culturing for 3 days, wherein the culture temperature is set to be 36 ℃.
5. The black tea active powder according to claim 3, wherein the step of strain purification and domestication comprises: taking a good Eurotium cristatum from a culture medium for culturing Eurotium cristatum, inoculating to a cooled and solidified PDA culture medium containing tea polyphenols and chlorogenic acid, and culturing in an incubator at 36 deg.C for 3 days.
6. The black tea active powder according to claim 3, wherein the strain enrichment step specifically comprises: taking a piece of eurotium cristatum with excellent growth vigor from a culture medium for culturing eurotium cristatum which is tolerant to the environment of tea polyphenol and chlorogenic acid, adding the eurotium cristatum into a PDW culture solution containing the tea polyphenol and the chlorogenic acid, placing the PDW culture solution in a constant-temperature culture shaking table for culturing for 3 days at the temperature of 36 +/-1 ℃ and the rotating speed of 180r/min, and scattering spores to obtain a bacterial solution enriched with eurotium cristatum mycelium pellets.
7. The dark tea active powder according to claim 3, wherein the step of obtaining mycelium specifically comprises: adding 5L of distilled water into a reaction kettle, sequentially adding tea polyphenol accounting for 5 percent of the total weight of the water, chlorogenic acid accounting for 5 percent of the total weight of the water, eurotium cristatum liquid accounting for 5 percent of the total weight of the water and fungus-culturing brown sugar accounting for 5 percent of the total weight of the water, stirring for 1 hour, setting the stirring condition to be 30r/min, and then naturally fermenting, wherein the temperature condition is controlled to be 36 +/-1 ℃ and the fermentation time is 2 weeks.
8. The black tea active powder according to claim 3, wherein the steps of freeze-dried mycelium → crushed solid state fermentation liquid → black tea active powder are as follows: and after the fermentation is finished, taking out the fermentation liquor containing a large amount of mycelia, performing membrane filtration to obtain pure fermentation liquor, performing freeze-drying by using a freeze dryer to obtain solid fermentation liquor, and crushing by using a crusher to obtain the required black tea active powder.
9. A solid beverage, which is characterized in that the solid beverage contains the dark green tea active powder as described in any one of claims 1 to 8, and the fixed beverage comprises a blood sugar-reducing dark green tea active powder solid beverage, a lipid-lowering dark green tea active powder solid beverage and an acid-reducing dark green tea active powder solid beverage.
10. The solid beverage as claimed in claim 9, wherein the formula of the hypoglycemic dark green tea active powder solid beverage is as follows: 20% of black tea active powder, 5% of dihydromyricetin, 2.5% of stevioside, 1.8% of mogroside, 33.3% of inulin, 10% of galacto-oligosaccharide, 12.3% of xylo-oligosaccharide, 5% of yeast beta-glucan and 10% of soybean phospholipid;
the formula of the lipid-lowering dark green tea active powder solid beverage comprises: 16.7% of black tea active powder, 2% of nuciferine, 3% of glycyrrhizic acid, 13.3% of galacto-oligosaccharide, 1.7% of mogroside, 6.7% of yeast beta-glucan, 6.7% of vitamin C, 8.3% of chitosan oligosaccharide, 1.7% of stevioside and 40% of inulin;
the formula of the acid-reducing dark green tea active powder solid beverage comprises: 18.3% of black tea active powder, 15% of potassium citrate, 10% of citric acid, 2% of pachyman, 30% of maltitol, 2.7% of stevioside, 2% of gamma-aminobutyric acid, 1% of vitamin C and 23.3% of soybean polysaccharide.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210081820.2A CN114431312A (en) | 2022-01-24 | 2022-01-24 | Black tea active powder and solid beverage thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210081820.2A CN114431312A (en) | 2022-01-24 | 2022-01-24 | Black tea active powder and solid beverage thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114431312A true CN114431312A (en) | 2022-05-06 |
Family
ID=81369466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210081820.2A Pending CN114431312A (en) | 2022-01-24 | 2022-01-24 | Black tea active powder and solid beverage thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114431312A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103305565A (en) * | 2013-06-13 | 2013-09-18 | 彭呈悦 | Preparation method of eurotium cristatum mycelium extract |
| CN107502561A (en) * | 2017-10-16 | 2017-12-22 | 四川大学 | Coronoid process dissipate capsule bacterium and its application, black tea and its processing method |
| CN107950707A (en) * | 2016-10-17 | 2018-04-24 | 福建奥正投资发展有限公司 | From allotment beverage composition for treating dental erosion, and its preparation method and application |
| CN108771242A (en) * | 2018-06-20 | 2018-11-09 | 西安巨子生物基因技术股份有限公司 | A kind of coronoid process dissipate capsule bacterium Fermentation Function compound and its preparation method and application |
| CN109198113A (en) * | 2018-11-12 | 2019-01-15 | 吉首大学 | A kind of compounding folium cortex eucommiae Fu-brick tea and preparation method thereof |
| CN109294929A (en) * | 2018-10-30 | 2019-02-01 | 中科沣文（天津）新能源科技有限公司 | A kind of preparation method of the coronoid process dissipate capsule bacterium bacterium powder for dark green tea fermentation |
| CN112293530A (en) * | 2020-11-03 | 2021-02-02 | 常德春峰茶业有限公司 | Production and processing method of Fuzhuan tea containing honeysuckle |
-
2022
- 2022-01-24 CN CN202210081820.2A patent/CN114431312A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103305565A (en) * | 2013-06-13 | 2013-09-18 | 彭呈悦 | Preparation method of eurotium cristatum mycelium extract |
| CN107950707A (en) * | 2016-10-17 | 2018-04-24 | 福建奥正投资发展有限公司 | From allotment beverage composition for treating dental erosion, and its preparation method and application |
| CN107502561A (en) * | 2017-10-16 | 2017-12-22 | 四川大学 | Coronoid process dissipate capsule bacterium and its application, black tea and its processing method |
| CN108771242A (en) * | 2018-06-20 | 2018-11-09 | 西安巨子生物基因技术股份有限公司 | A kind of coronoid process dissipate capsule bacterium Fermentation Function compound and its preparation method and application |
| CN109294929A (en) * | 2018-10-30 | 2019-02-01 | 中科沣文（天津）新能源科技有限公司 | A kind of preparation method of the coronoid process dissipate capsule bacterium bacterium powder for dark green tea fermentation |
| CN109198113A (en) * | 2018-11-12 | 2019-01-15 | 吉首大学 | A kind of compounding folium cortex eucommiae Fu-brick tea and preparation method thereof |
| CN112293530A (en) * | 2020-11-03 | 2021-02-02 | 常德春峰茶业有限公司 | Production and processing method of Fuzhuan tea containing honeysuckle |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108330080B (en) | Feed silage agent containing lactobacillus buchneri and preparation method and application thereof | |
| CN102864095B (en) | Lactobacillus plantarum used for silage alfalfa and use method thereof | |
| EP2727994B1 (en) | Novel lactic acid bacterium and method for preparing silage or fermented feed using same | |
| CN105942084A (en) | Method for producing probiotic functional food through buckwheat fermentation | |
| CN102864093B (en) | Lactobacillus plantarum suitable for silage straw and use method thereof | |
| CN108220071A (en) | A kind of preparation method of hickory chick yellow rice wine | |
| CN107568415A (en) | A kind of livestock and poultry biological fermentation feed | |
| CN112980646B (en) | Kefir source composite probiotic fermented pear juice and oat viable bacteria vinegar drink and preparation method thereof | |
| CN102273548B (en) | Feeding microecological preparation and preparation method thereof | |
| CN111642622A (en) | Preparation and application of fermentation composite bacteria and myrtle fermentation extract | |
| CN106387317A (en) | Microorganism feed additive capable of protecting pig livers and preparation method of microorganism feed additive | |
| CN113061061A (en) | Preparation method of chemical fertilizer rich in gamma-aminobutyric acid | |
| KR100745654B1 (en) | Medium for the lactobacilus spp. and production method of the lactobacilus spp. using therof | |
| CN103211098A (en) | Aflatoxin adsorbent and application | |
| CN111480729B (en) | Synergistic fermentation method of bacterial enzymes containing rapeseed meal | |
| CN109287853B (en) | Corn straw-soybean meal mixed fermentation material, and preparation method and application thereof | |
| CN114431312A (en) | Black tea active powder and solid beverage thereof | |
| CN113293101B (en) | Inactivation method and application of lactic acid bacteria | |
| KR101639604B1 (en) | Composition for curing hangover | |
| CN1718076A (en) | Method for preparing microoganism additives for ensiling lucerne | |
| CN112899117A (en) | Method for co-fermenting high gamma-aminobutyric acid red date and pearl barley vinegar by combining monascus with lactobacillus and spore bacteria | |
| CN111406928A (en) | Red date fermented food with function of improving chronic diarrhea and preparation method and application thereof | |
| CN1320106C (en) | Preparation method of composite bacterial additive of alfalfa ensilage | |
| CN117778278B (en) | Compound lactobacillus silage additive and preparation method and application thereof | |
| CN100381562C (en) | Microorganism additive of alfalfa ensilage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |